SCHEMBL7213723

SCHEMBL7213723

CCCOc1cccc(CBr)c1CBr

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.41
MAPT P10636 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CYP2A6 P11509 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
LTB4R Q15722 1/20 0.37
LTB4R2 Q9NPC1 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ATM Q13315 3/20 0.37
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
DRD3 P35462 1/20 0.36
HTR1B P28222 1/20 0.36
GRM5 P41594 1/20 0.35
KCNH2 Q12809 2/20 0.35
SLC6A2 P23975 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2710467 0.88 MCHR1 (0.44) MCHR1MAPTHTR2BLTB4RLTB4R2
SCHEMBL4171112 0.83 L3MBTL1 (0.52) MAPTL3MBTL1NPSR1HTR2CHTR2B
SCHEMBL31351903 0.83 L3MBTL1 (0.52) MAPTL3MBTL1NPSR1HTR2CHTR2B
SCHEMBL31351906 0.81 NPC1 (0.46) MCHR1MAPTL3MBTL1CYP2A6HTR2C
SCHEMBL2061864 0.77 IDO1 (0.42) MAPTHTR2CLMNACHRM2CHRM1
SCHEMBL31351901 0.74 CYP1A2 (0.56) MAPTL3MBTL1NPSR1CYP1A2CYP2C9
SCHEMBL7213720 0.74 MCHR1 (0.38) MCHR1MAPTNPSR1KCNH2SLC6A2
SCHEMBL561213 0.74 CYP1A2 (0.56) MAPTL3MBTL1NPSR1CYP1A2CYP2C9
SCHEMBL9302891 0.74 HTR1A (0.54) MAPTL3MBTL1DRD2BCHELMNA
SCHEMBL8127858 0.74 ALDH1A1 (0.43) MAPTL3MBTL1NPSR1ATMDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552044-B2 Dopamine receptors H. LUNDBECK A/S (DK) 2003-04-22 US disclosed
EP-0946542-B1 INDANE OR DIHYDROINDOLE DERIVATIVES LUNDBECK & CO AS H (DK) 2002-10-09 EP disclosed
US-6352988-B2 HIGH AFFINITY FOR D4 RECEPTORS; TREATMENT OF SCHIZOPHRENIA, OTHER PSYCHOSES, ANXIETY DISORDERS, DEPRESSION, ALCOHOL ABUSE, IMPULSE CONTROL DISORDERS, AGGRESSION H. LUNDBECK A/S (DK) 2002-03-05 US disclosed
US-20010021777-A1 Indane or dihydroindole derivatives H. LUNDBECK A/S (DK) 2001-09-13 US disclosed
US-20010020095-A1 Indane or dihydroindole derivatives H. LUNDBECK A/S (DK) 2001-09-06 US disclosed
US-6262087-B1 HAVE HIGH AFFINITY FOR D4 RECEPTORS; USEFUL IN THE TREATMENT OF CERTAIN PSYCHIATRIC AND NEUROLOGIC DISORDERS, INCLUDING PSYCHOSIS, DEPRESSION AND ANXIETY. H. LUNDBECK A/S (DK) 2001-07-17 US disclosed
EP-0946542-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H. LUNDBECK A/S (DK) 1999-10-06 EP disclosed
WO-1998028293-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H.LUNDBECK A/S (DK) 1998-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020095-A1 Indane or dihydroindole derivatives HTR4, GPR4, GPR174 MCHR1 81/4885MAPT 2009/4885L3MBTL1 3952/4885
US-20010021777-A1 Indane or dihydroindole derivatives HTR4, GPR4, GPR174 MCHR1 81/4885MAPT 2009/4885L3MBTL1 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.